We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.14B
1-Year Est. Return 139.27%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+139.27%
3 Year Est. Return
+309.04%
5 Year Est. Return
+400.83%
10 Year Est. Return
+1,509.99%
AUM
$1.2B
AUM Growth
+$250M
Cap. Flow
+$22.8M
Cap. Flow %
1.91%
Top 10 Hldgs %
53.97%
Holding
74
New
14
Increased
12
Reduced
6
Closed
12
Avg Time Held Equity + Options
13 quarters
Top 10 Avg Time Held Equity + Options
6.7 quarters
Top 20 Avg Time Held Equity + Options
7.7 quarters
Avg Time Held Equity only
19.4 quarters
Top 10 Avg Time Held Equity only
11.4 quarters
Top 20 Avg Time Held Equity only
11 quarters

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$11.5M
2
RGNX icon
Regenxbio
RGNX
+$7.68M
3
WOLF icon
Wolfspeed
WOLF
+$6.03M
4
CTLT icon
CATALENT, INC.
CTLT
+$4.39M
5
LAMR icon
Lamar Advertising Co
LAMR
+$3.61M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.69M
2
WTFC icon
Wintrust Financial
WTFC
+$4.44M
3
CLF icon
Cleveland-Cliffs
CLF
+$2.4M
4
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$1.75M
5
SLN icon
Silence Therapeutics
SLN
+$155K

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.05%
2 Financials 14.83%
3 Technology 11.85%
4 Consumer Staples 3.95%
5 Consumer Discretionary 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BMRN icon
51
BioMarin Pharmaceuticals
BMRN
$10.7B
$2.68M 0.22%
30,953
– –
2018 Q2
20 quarters
GME icon
52
PUT
GameStop
GME
$13.7B
$2.42M 0.2%
+100,000
New +$2.25M
2023 Q2
0 quarters
UBER icon
53
CALL
Uber
UBER
$146B
$2.16M 0.18%
+50,000
New +$1.86M
2023 Q2
0 quarters
ASA icon
54
ASA Gold and Precious Metals
ASA
$1.01B
$1.82M 0.15%
122,351
– –
2013 Q2
40 quarters
CLF icon
55
CALL
Cleveland-Cliffs
CLF
$7.35B
$1.68M 0.14%
+100,000
New +$1.59M
2023 Q2
0 quarters
NTLA icon
56
Intellia Therapeutics
NTLA
$1.76B
$1.09M 0.09%
26,646
– –
2018 Q2
20 quarters
CRSP icon
57
CRISPR Therapeutics
CRSP
$4.98B
$1.06M 0.09%
18,876
– –
2018 Q2
20 quarters
MPT icon
58
Medical Properties Trust
MPT
$1.88B
$926K 0.08%
100,000
– –
2022 Q4
2 quarters
RARE icon
59
Ultragenyx Pharmaceutical
RARE
$1.51B
$733K 0.06%
15,885
– –
2018 Q2
20 quarters
WVE icon
60
Wave Life Sciences
WVE
$646M
$702K 0.06%
192,722
– –
2018 Q2
20 quarters
CTLT icon
61
CALL
DELISTED
CATALENT, INC.
CTLT
$429K 0.04%
+9,900
New +$435K
2023 Q2
0 quarters
EDIT icon
62
Editas Medicine
EDIT
$422M
$237K 0.02%
28,797
– –
2018 Q2
20 quarters
AFMD icon
63
DELISTED
Affimed
AFMD
– –
-10,000
Closed -$74.6K –
CLF icon
64
Cleveland-Cliffs
CLF
$7.35B
– –
-151,500
Closed -$2.4M –
CVNA icon
65
CALL
Carvana
CVNA
$42.8B
– –
-750,000
Closed -$1.47M –
DXCM icon
66
CALL
DexCom
DXCM
$32.4B
– –
-100,000
Closed -$11.6M –
DXCM icon
67
DexCom
DXCM
$32.4B
– –
-100
Closed -$12.1K –
GDX icon
68
CALL
VanEck Gold Miners ETF
GDX
$26.6B
– –
-200,000
Closed -$6.47M –
KRE icon
69
State Street SPDR S&P Regional Banking ETF
KRE
$3.3B
– –
-40,000
Closed -$1.75M –
SLN icon
70
Silence Therapeutics
SLN
$600M
– –
-25,000
Closed -$155K –
TDOC icon
71
CALL
Teladoc Health
TDOC
$1.08B
– –
-150,000
Closed -$3.88M –
UBER icon
72
PUT
Uber
UBER
$146B
– –
-150,000
Closed -$4.75M –
WTFC icon
73
Wintrust Financial
WTFC
$9.73B
– –
-60,900
Closed -$4.44M –
FSR
74
CALL
DELISTED
Fisker Inc.
FSR
– –
-300,000
Closed -$1.84M –
1 2
3

Similar funds

SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
LMGAM
Liberty Mutual Group Asset Management Boston, Massachusetts $1.15B AUM 29.1% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
DWS
Discipline Wealth Solutions Greenville, South Carolina $1.15B AUM 20.96% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return

WS Management's Q2 2023 Portfolio in Review

As of Q2 2023, WS Management held 74 positions worth $1.2B, up 26% from $946M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

WS Management's Q2 2023 filing shows 14 new, 12 increased, 6 reduced and 12 closed positions. Its largest new stake was Wolfspeed: 118,400 shares worth $6.58M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $6.69M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 46% a quarter earlier, followed by Financials and Technology.

  • WS Management's largest Q2 2023 buy was Wolfspeed: 118,400 shares worth $6.58M.
  • WS Management added most to NVIDIA in Q2 2023, an estimated $11.5M increase.
  • WS Management's biggest Q2 2023 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $6.69M.
  • WS Management fully exited Wintrust Financial in Q2 2023, selling an estimated $4.44M.
  • WS Management's ten largest holdings make up 54% of its $1.2B portfolio in Q2 2023.
  • WS Management opened 14 new positions and closed 12 in Q2 2023.
  • WS Management's portfolio value rose 26% quarter-over-quarter to $1.2B.

Based on WS Management's 13F filing for Q2 2023, filed 10 Aug 2023.